Business
Faron to Present at Jefferies Conference 2021
Faron to Present at Jefferies Conference 2021.
About this update from Faron Pharmaceuticals Oy
[{"type":"text","content":"\n \n \n \n RNS Number : 4594S\n Faron Pharmaceuticals Oy\n 16 November 2021\n \n \n \n \n Faron Pharmaceuticals Ltd.\n \n \n (\"Faron\")\n \n \n \n \n \n Faron to Present at the Jefferies London Healthcare Conference\n \n \n \n \n \n Press Release, November 16, 2021 at 02:00 AM (EDT) / 07:00 AM (GMT) / 09:00 AM (EET)\n \n \n \n \n \n \n TURKU, FINLAND / BOSTON, MA\n \n \n \n \n - Faron Pharmaceuticals Ltd. (\n AIM: FARN, First North: FARON\n ), a clinical stage biopharmaceutical company focused on building the future of immunotherapy by harnessing the power of the immune system to tackle cancer and inflammation, today announced that Yrjö Wichmann, Vice President of Financing and Investor Relations, will present at the Jefferies London Healthcare Conference on Tuesday, November 16 at 05:40 am EDT / 10:40 am GMT / 12:40 pm EET. \n \n \n \n \n \n A link to Mr. Wichmann's presentation can be accessed on the \"Investors\" section on Faron's website at \n \n \n https://www.faron.com/investors\n \n \n .\n \n \n \n \n \n For more information please contact:\n \n \n \n \n \n Media Contact\n \n \n Faron Pharmaceuticals\n \n \n Eric Van Zanten\n \n \n Head of Communications\n \n \n \n \n [email protected]\n \n \n \n \n [email protected]\n \n \n Phone: +1 (610) 529-6219\n \n \n \n \n \n Investor Contact\n \n \n Stern Investor Relations \n \n \n Julie Seidel\n \n \n \n \n [email protected]\n \n \n \n \n Phone: +1 (212) 362-1200\n \n \n \n \n \n Cairn Financial Advisers LLP, Nomad\n \n \n Sandy Jamieson, Jo Turner\n \n \n Phone: +44 (0) 207 213 0880\n \n \n \n \n \n Peel Hunt LLP, Broker \n \n \n Christopher Golden, James Steel\n \n \n Phone: +44 (0) 20 7418 8900\n \n \n \n \n \n Sisu Partners Oy, Certified Adviser on Nasdaq First North\n \n \n Juha Karttunen\n \n \n Phone: +358 (0)40 555 4727\n \n \n Jukka Järvelä\n \n \n Phone: +358 (0)50 553 8990\n \n \n \n \n \n Consilium Strategic Communications\n \n \n Mary-Jane Elliott, David Daley, Lindsey Neville\n \n \n \n \n [email protected]\n \n \n \n \n Phone: +44 (0)20 3709 5700\n \n \n \n \n \n \n \n \n About Faron Pharmaceuticals Ltd\n \n \n Faron (AIM: FARN, First North: FARON) is a clinical stage biopharmaceutical company developing novel treatments for medical conditi...